Arcus Biosciences Inc (RCUS)
Number of days of payables
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Payables turnover | 8.11 | 11.31 | 9.80 | 9.06 | 7.18 | 7.02 | 9.64 | 4.05 | 5.35 | 9.68 | 4.19 | 4.60 | 7.43 | 4.79 | 3.43 | 2.15 | 2.81 | 4.68 | 2.93 | 12.60 | |
| Number of days of payables | days | 45.00 | 32.28 | 37.24 | 40.28 | 50.86 | 51.98 | 37.87 | 90.04 | 68.27 | 37.69 | 87.06 | 79.42 | 49.09 | 76.16 | 106.37 | 169.69 | 130.02 | 78.01 | 124.66 | 28.97 |
December 31, 2024 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 8.11
= 45.00
The number of days of payables for Arcus Biosciences Inc has shown fluctuations over the past few years. From March 31, 2020, to December 31, 2024, the number of days of payables has ranged from a low of 28.97 days to a high of 169.69 days.
The trend in the number of days of payables indicates that the company's ability to pay its suppliers has varied significantly. At periods where the number of days of payables was higher, such as in March 31, 2021, and December 31, 2020, Arcus Biosciences Inc took longer to settle its payables, which may indicate potential liquidity challenges or inefficient cash management.
Conversely, during periods where the number of days of payables was lower, like in September 30, 2024, the company was able to settle its payables more quickly, suggesting a stronger liquidity position or improved cash flow management.
Overall, analyzing the changes in the number of days of payables can provide insights into the company's management of working capital, cash flow, and potential financial risks related to its payment obligations.
Peer comparison
Dec 31, 2024